Form 3 Filing for Corbus Pharmaceuticals Holdings, Inc.

This filing is an initial statement of beneficial ownership of securities filed by Nishant Saxena, Chief Business Officer of Corbus Pharmaceuticals Holdings, Inc. The filing indicates that Mr. Saxena, through his attorney-in-fact Meghan Houghton, directly owns 3,500 shares of Corbus Pharmaceuticals Holdings, Inc. common stock. The filing was made on May 22, 2026, reporting beneficial ownership as of May 21, 2026. Additionally, an attached exhibit details a Power of Attorney granted by Nishant Saxena to Yuval Cohen, Sean Moran, and Meghan Houghton, authorizing them to execute and file various SEC forms, including Forms 3, 4, and 5, on his behalf regarding his holdings and transactions in Corbus Pharmaceuticals Holdings, Inc. securities.